Rk Asset Management Trimmed Its National Presto Industries (NPK) Position by $520,990 as Stock Value Declined; Cvs Health Corp. (CVS) Holder M Kraus & Company Has Lowered Position by $482,274

February 13, 2018 - By Linda Rogers

M Kraus & Company decreased its stake in Cvs Health Corp. (CVS) by 21.01% based on its latest 2017Q3 regulatory filing with the SEC. M Kraus & Company sold 5,954 shares as the company’s stock declined 4.23% while stock markets rallied. The institutional investor held 22,384 shares of the medical and nursing services company at the end of 2017Q3, valued at $1.82 million, down from 28,338 at the end of the previous reported quarter. M Kraus & Company who had been investing in Cvs Health Corp. for a number of months, seems to be less bullish one the $70.79 billion market cap company. The stock increased 0.69% or $0.48 during the last trading session, reaching $69.87. About 8.94M shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since February 13, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Rk Asset Management Llc decreased its stake in National Presto Industries (NPK) by 5.64% based on its latest 2017Q3 regulatory filing with the SEC. Rk Asset Management Llc sold 4,915 shares as the company’s stock declined 2.53% while stock markets rallied. The institutional investor held 82,164 shares of the capital goods company at the end of 2017Q3, valued at $8.75 million, down from 87,079 at the end of the previous reported quarter. Rk Asset Management Llc who had been investing in National Presto Industries for a number of months, seems to be less bullish one the $680.97M market cap company. The stock decreased 1.26% or $1.25 during the last trading session, reaching $97.75. About 261,734 shares traded or 442.03% up from the average. National Presto Industries, Inc. (NYSE:NPK) has risen 25.76% since February 13, 2017 and is uptrending. It has outperformed by 9.06% the S&P500.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 71 analyst reports since July 22, 2015 according to SRatingsIntel. Tigress Financial initiated the shares of CVS in report on Friday, April 28 with “Buy” rating. Leerink Swann maintained it with “Buy” rating and $85.0 target in Tuesday, November 21 report. Jefferies maintained the stock with “Hold” rating in Wednesday, October 18 report. Needham maintained CVS Health Corporation (NYSE:CVS) on Tuesday, January 2 with “Buy” rating. The stock has “Hold” rating by Jefferies on Wednesday, August 16. Cowen & Co maintained the shares of CVS in report on Tuesday, June 13 with “Buy” rating. Citigroup maintained the stock with “Neutral” rating in Monday, November 13 report. The firm earned “Buy” rating on Tuesday, January 30 by Needham. The rating was maintained by Robert W. Baird with “Hold” on Friday, October 27. The stock of CVS Health Corporation (NYSE:CVS) has “Outperform” rating given on Friday, February 9 by Leerink Swann.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It is negative, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Kentucky Retirement System Insurance Trust Fund has 0.39% invested in CVS Health Corporation (NYSE:CVS). Amg Funds Ltd Com holds 0.62% in CVS Health Corporation (NYSE:CVS) or 13,937 shares. Gotham Asset Limited Liability owns 727,254 shares for 0.87% of their portfolio. Atria Investments Ltd Liability Corporation holds 0.17% or 38,883 shares. Addenda Cap Inc invested 0.36% of its portfolio in CVS Health Corporation (NYSE:CVS). Tompkins Fin Corporation, New York-based fund reported 2,902 shares. Amer Beacon Advsrs Inc invested in 1,211 shares. Wasatch Advsrs holds 85,400 shares or 0.09% of its portfolio. 82,179 were reported by Palladium Ptnrs Limited. Iberiabank holds 0.2% of its portfolio in CVS Health Corporation (NYSE:CVS) for 15,030 shares. Rdl Fincl Incorporated has 15,259 shares. Advisor Llc has 0.44% invested in CVS Health Corporation (NYSE:CVS) for 27,695 shares. Signature Mngmt Inc holds 0.13% or 5,944 shares in its portfolio. Avalon Advisors, a Texas-based fund reported 106,826 shares. Eqis Cap Management holds 27,805 shares or 0.12% of its portfolio.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>